Literature DB >> 17000049

Insertional polymorphism of endogenous retrovirus HERV-K115 in schizophrenia.

Takeshi Otowa1, Mamoru Tochigi, Mark Rogers, Tadashi Umekage, Nobumasa Kato, Tsukasa Sasaki.   

Abstract

Retroviruses are implicated in the pathogenesis of schizophrenia. Human endogenous retrovirus type K115 (HERV-K115) is a full-length, potentially transcriptional retrovirus and is also polymorphic. We investigated the frequency of HERV-K115 in Japanese schizophrenia patients and healthy controls. No difference was found in the frequency between patients and controls (8.4% versus 9.4%, respectively). However, a marginal difference was observed in age at onset between the HERV-K positive and negative patients (p=0.057). The HERV-K115 insertion appeared to be more frequent in patients with younger onset than those with later onset. These results preliminarily suggest that HERV-K115 may not be associated with schizophrenia in general, but that it could play a partial role in early precipitation of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17000049     DOI: 10.1016/j.neulet.2006.09.004

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  An alternative approach to medical genetics based on modern evolutionary biology. Part 3: HERVs in diseases.

Authors:  Frank P Ryan
Journal:  J R Soc Med       Date:  2009-10       Impact factor: 5.344

Review 2.  Human endogenous retrovirus-K (HML-2): a comprehensive review.

Authors:  Marta Garcia-Montojo; Tara Doucet-O'Hare; Lisa Henderson; Avindra Nath
Journal:  Crit Rev Microbiol       Date:  2018-10-14       Impact factor: 7.624

3.  Cross-sectional dating of novel haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa before Homo sapiens.

Authors:  Aashish R Jha; Satish K Pillai; Vanessa A York; Elizabeth R Sharp; Emily C Storm; Douglas J Wachter; Jeffrey N Martin; Steven G Deeks; Michael G Rosenberg; Douglas F Nixon; Keith E Garrison
Journal:  Mol Biol Evol       Date:  2009-08-10       Impact factor: 16.240

Review 4.  Human endogenous retroviruses and the nervous system.

Authors:  Renée N Douville; Avindra Nath
Journal:  Handb Clin Neurol       Date:  2014

5.  Frequency of human endogenous retroviral sequences (HERV) K113 and K115 in the Polish population, and their effect on HIV infection.

Authors:  Katarzyna Zwolińska; Brygida Knysz; Jacek Gąsiorowski; Monika Pazgan-Simon; Andrzej Gładysz; Maciej Sobczyński; Egbert Piasecki
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

6.  The distribution of insertionally polymorphic endogenous retroviruses in breast cancer patients and cancer-free controls.

Authors:  Julia H Wildschutte; Daniel Ram; Ravi Subramanian; Victoria L Stevens; John M Coffin
Journal:  Retrovirology       Date:  2014-08-12       Impact factor: 4.602

7.  Inhibition of human endogenous retrovirus-K by antiretroviral drugs.

Authors:  Richa Tyagi; Wenxue Li; Danelvis Parades; Mario A Bianchet; Avindra Nath
Journal:  Retrovirology       Date:  2017-03-22       Impact factor: 4.602

8.  The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity.

Authors:  Marta Garcia-Montojo; María Dominguez-Mozo; Ana Arias-Leal; Ángel Garcia-Martinez; Virginia De las Heras; Ignacio Casanova; Raphaël Faucard; Nadège Gehin; Alexandra Madeira; Rafael Arroyo; François Curtin; Roberto Alvarez-Lafuente; Hervé Perron
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

Review 9.  Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease.

Authors:  Cécile Voisset; Robin A Weiss; David J Griffiths
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 13.044

Review 10.  Human Endogenous Retroviruses as Pathogenic Factors in the Development of Schizophrenia.

Authors:  Gorjan Slokar; Gregor Hasler
Journal:  Front Psychiatry       Date:  2016-01-11       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.